Smokeless Tobacco Use
6
0
0
5
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Treatment Research
7 treatments under study, led by Quitaid Pharmacistdelivered Mtm
Research Leaders
5 sponsors active, led by National Cancer Institute (NCI)
Related Conditions
Often studied with 4 related conditions
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 15/100
0.0%
0 terminated out of 6 trials
100.0%
+13.4% vs benchmark
17%
1 trials in Phase 3/4
80%
4 of 5 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 5 completed trials
Clinical Trials (6)
Feasibility of a Medical-Legal Partnership Model to Connect Coal Miners QuitAid
A Pilot Study Evaluating Nicotine Lozenges and Self Help
Novel Determinants and Measures of Smokeless Tobacco Use: Study 1
Highdose Nicotine Patch Therapy for Smokeless Tobacco Use
Nicotine Lozenges for Treatment of Smokeless Tobacco Addiction
An Internet-Based Smokeless Tobacco Cessation Program for Teens
Research Network
Common Treatments
- Quitaid Pharmacistdelivered Mtm1
- Nicotine Lozenges1
- Tailored Enhanced Condition1
- Nicotine Replacement Therapy1
- Usual Care1
Active Sponsors
- National Cancer Institute (NCI)3
- Mayo Clinic3
- Oregon Research Institute2
- University of Minnesota1
- University of Virginia1
Top Investigators
Mayo Clinic
University of Virginia
University of Minnesota
Mayo Clinic
Oregon Research Institute
Related Conditions
- Nicotine Dependence1
- Tobacco Use Cessation1
- Tobacco Use Disorder1
- Tobacco Dependence1